Logo

Nectar Lifesciences Share Price

Nectar Lifesciences (INR)38.220.7   (2%)

Exchange ScripsBSE532649NSENECLIFEISININE023H01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Nectar Lifesciences Performance

Market performance
Open price38.1
High38.22
Volumes937046
Prev Close38.22
Low37.65
Closing date2025-01-14
Historical performance
1 Year High56.50
3 Year High56.50
5 Year High56.50
1 Year Low26.15
3 Year Low14.50
5 Year Low7.10

Nectar Lifesciences Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
841
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
171.62
Dividend Yield
Dividend Yield
N/A

Nectar Lifesciences Investment Returns

1 Year
11.4%
3 Years
25.1%
5 Years
176%
10 Years
18.1%

Nectar Lifesciences Technicals

IndicatorsValueSignal
5-DMA38.12Bullish
10-DMA39Bearish
20-DMA39.87Bearish
50-DMA37.23Bullish
100-DMA39.17Bearish
200-DMA35.77Bullish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters32222
Foreign Investors---------------
Domestic Investors32222
Public Investors6947966738582275994360758
Government11111

Nectar Lifesciences Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income243531113114
Operating Profit1759106116991128
Interest9698947881120
Depreciation607591570603
Profit Before Tax183-424341-848
Consolidated Net Profit50-242250-733
Adjusted EPS----11-3

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital224224224224
Total Reserves10468104221065510396
Minority Interest------------
Total Non-Current Liabilities1415213129631264
Total Liabilities21836216862388023758
Capital Work in Progress658778851986
Total Assets21836216862388023758

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities22471337950214
Cash Flow from Investing Activities-170517166-286
Cash Flow from Financing Activitie-2054-1856-1194115
Net Cash Inflow / Outflow22-2-7742
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 171.62.
  • 3Y Stock Price CAGR of the stock is 1.4.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹1759 Million.
  • The company generated revenue of ₹16841 Million in the previous financial year.

Nectar Lifesciences

38.220.7   (2%)

Investment Amount: ₹ 3430
Current Value: ₹ 3822
Performance: 11.4%
P/L: ₹ 392
Top Gainers
SymbolChange%
SURYAROSNI280.05(20%)
BRNL47.17(20%)
ADANIPOWER537(19%)
KHANDSE29.12(19%)
IOB53.77(18%)
Top Losers
SymbolChange%
SABTNL845.05(-10%)
HCLTECH1813.55(-9%)
DNAMEDIA5.8(-8%)
KFINTECH1172.2(-7%)
PRSMJOHNSN152.92(-6%)
YAARI13.88(-5%)
UNITDSPR1407.25(-5%)
TVVISION12.77(-5%)
Similar stocks

Zota Health Care

44.3

989.5

December 14 - January 14

Bajaj Healthcare

29

545

December 14 - January 14

Medico Remedies

23.6

61.98

December 14 - January 14

Brooks Laboratories

15.9

174.84

December 14 - January 14

Blue Jet Healthcare

15.8

581.4

December 14 - January 14

Concord Biotech

10.2

2327.4

December 14 - January 14

Biocon

9.9

387.65

December 14 - January 14

Gufic Biosciences

8.8

469.5

December 14 - January 14

Announcing Stock of the Month!

Stock of the Month
Stock of the Month